2,219 Shares in Healthpeak Properties, Inc. (NYSE:DOC) Acquired by Kestra Investment Management LLC

Kestra Investment Management LLC acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 2,219 shares of the real estate investment trust’s stock, valued at approximately $45,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. State Street Corp purchased a new position in Healthpeak Properties during the third quarter worth approximately $1,093,576,000. JPMorgan Chase & Co. lifted its position in Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Principal Financial Group Inc. lifted its position in Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after buying an additional 17,314,572 shares in the last quarter. Geode Capital Management LLC purchased a new position in Healthpeak Properties during the third quarter worth approximately $403,898,000. Finally, Charles Schwab Investment Management Inc. purchased a new position in Healthpeak Properties during the third quarter worth approximately $230,988,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on DOC shares. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a research note on Wednesday, January 15th. Wedbush cut their target price on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 14th. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Wells Fargo & Company cut their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Finally, Royal Bank of Canada raised their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average price target of $24.00.

Healthpeak Properties Trading Down 0.1 %

Shares of NYSE DOC opened at $19.75 on Friday. Healthpeak Properties, Inc. has a twelve month low of $16.01 and a twelve month high of $23.26. The stock has a market capitalization of $13.81 billion, a PE ratio of 56.42, a PEG ratio of 2.14 and a beta of 1.15. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock has a fifty day simple moving average of $20.20 and a 200-day simple moving average of $21.39.

Healthpeak Properties Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Friday, February 14th will be paid a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a yield of 6.18%. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date is Friday, February 14th. Healthpeak Properties’s payout ratio is presently 348.58%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.